Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
recent
Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors
May
31
,
2024
DEA: MIRA-55 Marijuana Analog Not a Controlled Substance
May
29
,
2024
Psilocybin Clinical Trial for Mental-Health Workers Approved in Canada
May
24
,
2024
Psilocybin Spurs Dynamic Brain ‘Hyperconnectivity’ Linked to Psychedelic Epiphanies
May
24
,
2024
Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD
May
17
,
2024
BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle
May
15
,
2024
«
‹
3
4
5
6
›
»